NCT05986968View on ClinicalTrials.gov

Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
ST Elevation Myocardial Infarction
Interventions
DRUG

Ticagrelor

Ticagrelor monotherapy for 12 months

DRUG

Aspirin

Dual antiplatelet therapy (aspirin plus ticagrelor) for 12 months

Trial Locations (5)

Unknown

RECRUITING

Noordwest Ziekenhuisgroep Alkmaar, Alkmaar

RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

Rijnstate, Arnhem

RECRUITING

Medisch Spectrum Twente, Enschede

RECRUITING

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER